Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Susan Barrett
Observed names:
S. Barrett,
S.A. Barrett,
Susan A. Barrett
Institutions:
Commonwealth Scientific and Industrial Research Organisation,
CSIRO Manufacturing
Observed institutions:
Griffith University,
Commonwealth Scientific and Industrial Research Organisation,
Australian Centre for Disease Preparedness,
CSIRO Manufacturing
ORCID:
0000-0003-1132-5268
Observed ORCID:
0000-0003-1132-5268
OpenAlex ID:
A5028483003
The characterization and molecular cloning of the double-stranded RNA genome of an Australian strain of infectious bursal disease virus
1985
·
A.A. Azad
, S.A. Barrett
, et al.
·
Virology
·
228
Mechanism-Based Covalent Neuraminidase Inhibitors with Broad-Spectrum Influenza Antiviral Activity
2013
·
Jin-Hyo Kim
, Ricardo Resende
, et al.
·
Science
·
218
Structural and Functional Basis of Resistance to Neuraminidase Inhibitors of Influenza B Viruses
2010
·
Aaron J. Oakley
, Susan Barrett
, et al.
·
Journal of Medicinal Chemistry
·
93
PDF
A Generic System for the Expression and Purification of Soluble and Stable Influenza Neuraminidase
2011
·
Peter M. Schmidt
, Rebecca M. Attwood
, et al.
·
PLoS ONE
·
53
PDF
Reduced susceptibility to all neuraminidase inhibitors of influenza H1N1 viruses with haemagglutinin mutations and mutations in non-conserved residues of the neuraminidase
2013
·
Jennifer L. McKimm-Breschkin
, Janelle Williams
, et al.
·
Journal of Antimicrobial Chemotherapy
·
47
PDF
Expression in Escherichia coli of cDNA fragments encoding the gene for the host-protective antigen of infectious bursal disease virus
1986
·
A.A. Azad
, K.J. Fahey
, et al.
·
Virology
·
43
Real Time Enzyme Inhibition Assays Provide Insights into Differences in Binding of Neuraminidase Inhibitors to Wild Type and Mutant Influenza Viruses
2011
·
Susan Barrett
, Peter G. Mohr
, et al.
·
PLoS ONE
·
40
PDF
I222 Neuraminidase Mutations Further Reduce Oseltamivir Susceptibility of Indonesian Clade 2.1 Highly Pathogenic Avian Influenza A(H5N1) Viruses
2013
·
Jennifer L. McKimm-Breschkin
, Susan Barrett
, et al.
·
PLoS ONE
·
34
PDF
In vitro passaging of a pandemic H1N1/09 virus selects for viruses with neuraminidase mutations conferring high-level resistance to oseltamivir and peramivir, but not to zanamivir
2012
·
J. L. McKimm-Breschkin
, C. Rootes
, et al.
·
Journal of Antimicrobial Chemotherapy
·
33
Supplementation with a single and double strain probiotic on the innate immune system for respiratory illness
2014
·
Nicholas P. West
, Peggy L. Horn
, et al.
·
e-SPEN Journal
·
28
Catalytic mechanism and novel receptor binding sites of human parainfluenza virus type 3 hemagglutinin-neuraminidase (hPIV3 HN)
2015
·
Victor A. Streltsov
, Pat Pilling
, et al.
·
Antiviral Research
·
23
Crowder-directed interactions and conformational dynamics in multistimuli-responsive intrinsically disordered protein
2022
·
Rajkamal Balu
, Nisal Wanasingha
, et al.
·
Science Advances
·
19
Neuraminidase mutations conferring resistance to laninamivir lead to faster drug binding and dissociation
2014
·
Jennifer L. McKimm-Breschkin
, Susan Barrett
·
Antiviral Research
·
19
Identification of Indonesian clade 2.1 highly pathogenic influenza A(H5N1) viruses with N294S and S246N neuraminidase substitutions which further reduce oseltamivir susceptibility
2018
·
Jennifer L. McKimm-Breschkin
, Susan Barrett
, et al.
·
Antiviral Research
·
15
PDF
Structural and Functional Analysis of Anti-Influenza Activity of 4-, 7-, 8- and 9-Deoxygenated 2,3-Difluoro-N-acetylneuraminic Acid Derivatives
2018
·
Jennifer L. McKimm-Breschkin
, Susan Barrett
, et al.
·
Journal of Medicinal Chemistry
·
11
Passaging of an influenza A(H1N1)pdm09 virus in a difluoro sialic acid inhibitor selects for a novel, but unfit I106M neuraminidase mutant
2019
·
Jennifer L. McKimm-Breschkin
, Susan Barrett
, et al.
·
Antiviral Research
·
7
Solid phase assay for comparing reactivation rates of neuraminidases of influenza wild type and resistant mutants after inhibitor removal
2014
·
Susan Barrett
, Jennifer L. McKimm-Breschkin
·
Antiviral Research
·
5
Influenza Virus Neuraminidase N9 in Complex With 9-deoxygenated 2,3-difluoro-n-acetylneuraminic Acid
2017
·
V.A. Streltsov
, J. Mckimm-Breschkin
, et al.
·
Worldwide Protein Data Bank
Influenza Virus Neuraminidase N9 in Complex With 8-deoxygenated 2,3-difluoro-n-acetylneuraminic Acid
2017
·
V.A. Streltsov
, J. Mckimm-Breschkin
, et al.
·
Worldwide Protein Data Bank
Influenza Virus Neuraminidase N9 in Complex With 7-deoxygenated 2,3-difluoro-n-acetylneuraminic Acid
2017
·
V.A. Streltsov
, J. Mckimm-Breschkin
, et al.
·
Worldwide Protein Data Bank
Influenza Virus Neuraminidase N9 in Complex With 4-deoxygenated 2,3-difluoro-n-acetylneuraminic Acid
2017
·
V.A. Streltsov
, J. Mckimm-Breschkin
, et al.
·
Worldwide Protein Data Bank
Structure of the Hemagglutinin-neuraminidase from Human parainfluenza virus type III: complex with difluorosialic acid
2015
·
V.A. Streltsov
, P. Pilling
, et al.
·
Worldwide Protein Data Bank
influenza virus neuraminidase N9 in complex 2,3-difluorosialic acid
2014
·
V.A. Streltsov
, P. Pilling
, et al.
·
Worldwide Protein Data Bank
Show more works
View as search
Works count:
23
Citation count:
916
H-index:
14
I10-index:
15
Year
Topic
Type